Robert S. Epstein, Director of Fate Therapeutics FATE, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $1.2M. The latest trade was on 06/12.

RE

RE

Robert S. Epstein

Director

Company

Fate Therapeutics FATE

First filing

23/05/25

Trades

26 trades

Buys / sales

0 / 3

12-month net buying

−$1.2M

Last trade

06/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
VeracyteVCYT	Open-market sale10b5-1 plan	05/20	05/22	10,000 sh	$44.01	$440,100	−16.0%
VeracyteVCYT	Open-market sale10b5-1 plan	25/10/01	25/10/03	21,473 sh	$35.08	$753,272.84	−25.6%
VeracyteVCYT	Open-market sale10b5-1 plan	24/11/12	24/11/14	15,000 sh	$38.32	$574,800	−25.2%